Clinical outcome study in dysferlinopathy: medical comorbidities and polytherapy in a large population of dysferlinopathy patients

被引：0

作者：

Fernandez-Torron, R. ^{[1
]}

Diaz-Manera, J. ^{[2
]}

James, M. ^{[3
]}

Mayhew, A. ^{[3
]}

Spuler, S. ^{[4
]}

Day, J. ^{[5
]}

Jones, K. ^{[6
]}

Bharucha-Goebel, D. ^{[7
]}

Salort-Campana, E. ^{[8
]}

Pestronk, A. ^{[9
]}

Walter, M. ^{[10
]}

Paradas, C. ^{[11
]}

Stojkovic, T. ^{[12
]}

Mori-Yoshimura, M. ^{[13
]}

Bravver, E. ^{[14
]}

Pegoraro, E. ^{[15
]}

Mendell, J. ^{[16
]}

Bushby, K. ^{[3
]}

Straub, V. ^{[3
]}

机构：

[1] Hosp Donostia, Donostia San Sebastian, Spain

[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[3] John Walton Muscular Dystrophy, Newcastle Upon Tyne, Tyne & Wear, England

[4] Charite Med Fac, Berlin, Germany

[5] Stanford Univ, Stanford, CA 94305 USA

[6] Westmead Childrens Hosp, Sydney, NSW, Australia

[7] Childrens Natl Hlth, Washington, DC USA

[8] La Timone Hosp, Marseille, France

[9] Washington Univ, St Louis, MO USA

[10] Univ Munich, Munich, Germany

[11] Hosp Univ Virgen del Rocio, Seville, Spain

[12] Inst Myol, Paris, France

[13] NCNP, Tokyo, Japan

[14] Carolinas Healthcare, Charlotte, NC USA

[15] Univ Padua, Padua, Italy

[16] Nationwide Childrens Hosp, Columbus, OH USA

[17] Jain Consortium, Seattle, WA USA

来源：

NEUROMUSCULAR DISORDERS | 2018年 / 28卷

关键词：

D O I：

10.1016/j.nmd.2018.06.041

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.12

引用

页码：S35 / S35

页数：1

共 50 条

[1] Clinical Outcome Study of Dysferlinopathy: what are the best outcome measures for dysferlinopathy patients?
James, M. K.
Jacobs, M.
Mayhew, A.
Feng, J.
Spuler, S.
Day, J. W.
Jones, K. J.
Bharucha-Goebel, D. X.
Salort-Campana, E.
Pestronk, A.
Walter, M. C.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Manera, J. Diaz
Pegoraro, E.
Mendell, J. R.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2018, 28 : S6 - S6
[2] The clinical outcome study for dysferlinopathy: pregnancy in dysferlinopathy
Moore, U.
James, M.
Jacobs, M.
Mayhew, A.
Spuler, S.
Day, J.
Bharucha-Goebel, D.
Stojkovic, T.
Mendell, J.
Straub, V.
NEUROMUSCULAR DISORDERS, 2019, 29 : S104 - S104
[3] Clinical outcome study of dysferlinopathy: what are the best outcome measures for dysferlinopathy patients?
James, M.
Jacobs, M.
Mayhew, A.
Feng, J.
Spuler, S.
Day, J.
Jones, K.
Bharucha-Goebel, D.
Salort-Campana, E.
Pestronk, A.
Walter, M.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Diaz-Manera, J.
Pegoraro, E.
Mendell, J.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2017, 27 : S227 - S227
[4] The International Dysferlinopathy Registry and an international clinical outcome study for dysferlinopathy
von Rekowski, B.
Blandin, G.
Krahn, M.
Beroud, C.
De Waele, L.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2012, 22 : S35 - S35
[5] Quality of life in adults with dysferlinopathy: international clinical outcome study of dysferlinopathy
Hilsden, H.
James, M.
Dressman, H. Gordish
Day, J.
Mendell, J.
Torron, R. Fernandez
Harms, M.
Pestronk, A.
Vissing, J.
Desai, U.
Yoshimura, M.
Shin, J.
Mozaffar, T.
Stojkovic, T.
Pegoraro, E.
Raivas, J. Bevilacqu
Olive, M.
Paradas, C.
Straub, V.
Mayhew, A.
NEUROMUSCULAR DISORDERS, 2023, 33 : S113 - S113
[6] THE INTERNATIONAL CLINICAL OUTCOME STUDY IN DYSFERLINOPATHY
Ghaoui, Roula
Meredith, James
Fernandez-Torron, Roberto
Moore, Ursula
Diaz-Manera, Jordi
Smith, Fiona E.
Mayhew, Anna
Jones, Kristi J.
Bushby, Kate
Straub, Volker
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
[7] North Star Assessment for dysferlinopathy: Longitudinal performance in the clinical outcome study of dysferlinopathy
James, M.
Mayhew, A.
Eagle, M.
Lofra, R. Muni
Maron, E.
Gee, R.
Harman, M.
Duong, T.
Vandevelde, B.
Siener, C.
Thiele, S.
Mendez, J.
Canal, A.
Sakamoto, C.
Holsten, S.
Pedrosa-Hernandez, I.
Semplicini, C.
Lowes, L.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2017, 27 : S145 - S145
[8] Is cardiac dysfunction a feature of dysferlinopathy? Data from the clinical outcome study of dysferlinopathy
Torron, R. Fernandez
Harris, E.
Bourke, J.
Bettinson, K.
Hilsden, H.
Spuler, S.
Day, J.
Jones, K.
Bharucha-Goebel, D.
Salort-Campana, E.
Pestronk, A.
Walter, M.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Diaz-Manera, J.
Pegoraro, E.
Mendell, J.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2017, 27 : S145 - S145
[9] Is cardiac dysfunction a feature of dysferlinopathy? Data from the Clinical Outcome Study of Dysferlinopathy
Tiet, M.
Fernandez-Torron, R.
Bourke, J.
Bettinson, K.
Harris, E.
Hilsden, H.
Spuler, S.
Day, J. W.
Jones, K. J.
Bharucha-Goebel, D. X.
Salort-Campana, E.
Pestronk, A.
Walter, M. C.
Paradas, C.
Stojkovic, T.
Mori-Yoshimura, M.
Bravver, E.
Manera, J. Diaz
Pegoraro, E.
Mendell, J. R.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2018, 28 : S5 - S6
[10] The Clinical Outcome Study for dysferlinopathy An international multicenter study
Harris, Elizabeth
Bladen, Catherine L.
Mayhew, Anna
James, Meredith
Bettinson, Karen
Moore, Ursula
Smith, Fiona E.
Rufibach, Laura
Cnaan, Avital
Bharucha-Goebel, Diana X.
Blamire, Andrew M.
Bravver, Elena
Carlier, Pierre G.
Day, John W.
Diaz-Manera, Jordi
Eagle, Michelle
Grieben, Ulrike
Harms, Matthew
Jones, Kristi J.
Lochmueller, Hanns
Mendell, Jerry R.
Mori-Yoshimura, Madoka
Paradas, Carmen
Pegoraro, Elena
Pestronk, Alan
Salort-Campana, Emmanuelle
Schreiber-Katz, Olivia
Semplicini, Claudio
Spuler, Simone
Stojkovic, Tanya
Straub, Volker
Takeda, Shin'ich
Rocha, Carolina Tesi
Walter, M. C.
Bushby, Kate
NEUROLOGY-GENETICS, 2016, 2 (04)

← 1 2 3 4 5 →